Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells.

[1]  J. Rasko,et al.  Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study , 2020, Nature medicine.

[2]  S. Chand,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications , 2020, Frontiers in Cell and Developmental Biology.

[3]  K. Tarte,et al.  Integrated transcriptomic, phenotypic, and functional study reveals tissue‐specific immune properties of mesenchymal stromal cells , 2020, Stem cells.

[4]  I. Martin,et al.  Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. , 2019, Cytotherapy.

[5]  S. Hoerstrup,et al.  Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential , 2019, npj Regenerative Medicine.

[6]  F. Baron,et al.  Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model , 2019, Front. Immunol..

[7]  Avi Ma’ayan,et al.  Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells , 2019, Nature Cell Biology.

[8]  H. Volk,et al.  Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. , 2019, Trends in molecular medicine.

[9]  Min Lee,et al.  Relative contributions of adipose-resident CD146+ pericytes and CD34+ adventitial progenitor cells in bone tissue engineering , 2019, npj Regenerative Medicine.

[10]  D. Cyranoski.  Japan’s approval of stem-cell treatment for spinal-cord injury concerns scientists , 2019, Nature.

[11]  Y. Kaneda,et al.  Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins , 2018, Scientific Reports.

[12]  J. Galipeau,et al.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. , 2018, Cell stem cell.

[13]  M. Remberger,et al.  Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease , 2018, Stem cells translational medicine.

[14]  R. Seetharam,et al.  Administration of Adult Human Bone Marrow‐Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger’s Disease: Phase II Study Report Suggests Clinical Efficacy , 2016, Stem cells translational medicine.

[15]  Ivan Martin,et al.  International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. , 2016, Cytotherapy.

[16]  ViswanathanSowmya,et al.  Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. , 2014 .

[17]  I. Slaper-Cortenbach,et al.  Standards for the Terminology and Labeling of Cellular Therapy Products , 2007, Transfusion.

[18]  D. Jacobsohn.  Acute graft-versus-host disease in children , 2008, Bone Marrow Transplantation.

[19]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[20]  F. Marini,et al.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.

[21]  J. Chang,et al.  Molecular Sciences Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy , 2022 .